Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Mar;33(3):257-64.
doi: 10.1007/BF00665950.

Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer

Affiliations

Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer

M Cohen et al. Breast Cancer Res Treat. 1995 Mar.

Abstract

The use of the conventional combination oral contraceptives (containing ethinyl-estradiol and a progestin) is associated with reduced risk of ovarian and endometrial cancer. However, prolonged use of these pills before first term pregnancy apparently increases the risk of pre menopausal breast cancer. We propose that the pineal gland hormone melatonin, combined with a progestin, as a new and novel oral contraceptive combination might prevent breast cancer in long term users. This hypothesis is based on the assumption that women have a propensity to develop breast cancer which correlates with number of ovulatory cycles over their lifetime. In evolution, the phylogenetic point at which women became sensitive to breast cancer evolved at a transfer point of the mechanism of ovulation from seasonal ovulation, which is still common in many mammalian species, to the current human pattern of continuous ovulatory cycles. We suggest that melatonin/ovarian-steroid contraceptive will restore the lost mechanism of endogenous anovulation, and thus, by preventing continuous epithelial breast cell proliferation, will reduce the risk of breast cancer in long-term users.

PubMed Disclaimer

Similar articles

Cited by

  • Melatonin: Countering Chaotic Time Cues.
    Arendt J. Arendt J. Front Endocrinol (Lausanne). 2019 Jul 16;10:391. doi: 10.3389/fendo.2019.00391. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379733 Free PMC article.

References

    1. Am J Pathol. 1988 Jan;130(1):193-204 - PubMed
    1. Hum Pathol. 1977 Jan;8(1):67-81 - PubMed
    1. J Pineal Res. 1990;8(3):269-76 - PubMed
    1. Gynecol Oncol. 1994 Mar;52(3):292-5 - PubMed
    1. Lancet. 1978 Oct 14;2(8094):814-6 - PubMed

MeSH terms

LinkOut - more resources